Related Experiment Video
Updated: Feb 3, 2026

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Published on: October 29, 2019
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C Ämmälä1, W J Drury1, L Knerr1
1Cardiovascular Renal and Metabolic Diseases, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
Abstract:
Antisense oligonucleotide (ASO) silencing of the expression of disease-associated genes is an attractive novel therapeutic approach, but treatments are limited by the ability to deliver ASOs to cells and tissues. Following systemic administration, ASOs preferentially accumulate in liver and kidney. Among the cell types refractory to ASO uptake is the pancreatic insulin-secreting β-cell. Here, we show that conjugation of ASOs to a ligand of the glucagon-like peptide-1 receptor (GLP1R) can productively deliver ASO cargo to pancreatic β-cells both in vitro and in vivo. Ligand-conjugated ASOs silenced target genes in pancreatic islets at doses that did not affect target gene expression in liver or other tissues, indicating enhanced tissue and cell type specificity. This finding has potential to broaden the use of ASO technology, opening up novel therapeutic opportunities, and presents an innovative approach for targeted delivery of ASOs to additional cell types.
Insights
Targeted delivery of antisense oligonucleotides (ASOs) to pancreatic beta cells was achieved by conjugating ASOs to a glucagon-like peptide-1 receptor (GLP1R) ligand, enhancing therapeutic potential.
Area of Science:
- Biotechnology
- Molecular Biology
- Pharmacology
Background:
- Antisense oligonucleotides (ASOs) offer a novel therapeutic strategy for silencing disease-associated genes.
- Current ASO delivery methods face limitations, with preferential accumulation in the liver and kidney, and poor uptake by pancreatic beta cells.
Purpose of the Study:
- To develop a targeted delivery method for ASOs to pancreatic beta cells.
- To investigate the efficacy and specificity of ASO delivery mediated by a glucagon-like peptide-1 receptor (GLP1R) ligand.
Main Methods:
- Conjugation of ASOs to a GLP1R-targeting ligand.
- In vitro and in vivo studies to assess ASO delivery and gene silencing in pancreatic beta cells.
- Evaluation of gene expression in pancreatic islets, liver, and other tissues.
Main Results:
- GLP1R-ligand conjugated ASOs successfully delivered cargo to pancreatic beta cells both in vitro and in vivo.
- Target gene silencing was observed in pancreatic islets at specific doses.
- Enhanced tissue and cell type specificity was demonstrated, with no significant effect on gene expression in the liver or other tissues.
Conclusions:
- Conjugating ASOs to GLP1R ligands provides a novel and effective strategy for targeted delivery to pancreatic beta cells.
- This approach broadens the therapeutic applications of ASO technology.
- The method presents an innovative platform for targeted ASO delivery to various cell types.
Related Concept Videos
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
TGF - β Signaling Pathway
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

